Related Experiment Videos
Topical carbonic anhydrase inhibitors.
Journal of Medicinal Chemistry
|June 1, 1984
Summary
New ethoxzolamide derivatives were synthesized to improve carbonic anhydrase inhibition. The 6-chloro derivative showed the best properties for reducing intraocular pressure and was most potent in rabbit models.
Area of Science:
- Medicinal Chemistry
- Ophthalmology
- Pharmacology
Background:
- Carbonic anhydrase inhibitors are crucial for managing intraocular pressure.
- Ethoxzolamide is a known carbonic anhydrase inhibitor.
- Optimizing drug properties is key for effective glaucoma treatment.
Purpose of the Study:
- To synthesize and evaluate novel ethoxzolamide derivatives.
- To assess carbonic anhydrase inhibition (CAI), solubility, pKa, distribution, and corneal permeability.
- To identify derivatives with enhanced potential for reducing intraocular pressure.
Main Methods:
- Synthesis of ethoxzolamide derivatives (1-6).
- In vitro evaluation of CAI, solubility, pKa, and distribution.
- In vivo assessment of corneal permeability and topical effectiveness in rabbit models.
Main Results:
- Derivatives 5 (6-hydroxy) and 6 (6-chloro) demonstrated favorable properties for ocular penetration.
- Both derivatives 5 and 6 showed topical effectiveness in reducing intraocular pressure in rabbits.
- Derivative 6 exhibited superior potency compared to derivative 5.
Conclusions:
- Ethoxzolamide derivatives, particularly the 6-chloro analogue (6), offer improved characteristics for ocular drug delivery.
- These novel compounds show promise for the development of more effective treatments for glaucoma.
- Further research into derivative 6 could lead to enhanced intraocular pressure reduction therapies.